REMICADE (infliximab) for Rheumatoid Arthritis
Links shared publicly online about this topic.
- 1,220total visits
REMICADE (infliximab) for Rheumatoid Arthritis
View full resource at remicade.com
Tags: Crohn's Disease Medication, Ulcerative Colitis Medication, Arthritis, Rheumatoid Arthritis, Rheumatoid Arthritis Medication, Remicade
Most Recently Shared on April 23, 2010 at 3:42 am By:
Learn how using Remicade can change the course of your rheumatoid arthritis. http://bit.ly/91P7AU
Journal of Medical Case Reports | Abstract | Pneumococcal polyarticular septic arthritis after a single infusion of infliximab in a rheumatoid arthritis patient: a case report
jmedicalcasereports.com — “We present a rare case of Streptococcus pneumoniae polyarticular septic arthritis in a patient with rheumatoid arthritis receiving a single infusion of infliximab.” View full resource at jmedicalcasereports.com
Most Recently Shared on March 15, 2012 at 11:50 am By:
Abstract | Pneumococcal polyarticular septic arthritis after a single ... http://t.co/hcAk7wzA
EMA CHMP issues positive opinion to MSD's REMICADE for treatment of pediatric UC
news-medical.net — “MSD today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending the use of REMICADE (infliximab) in the treatment of severely active ulcerative colitis (UC) in pediatric patients ages 6 to 17 years, who have had an inadequate response to conventional therapy, including corticosteroids and 6-mercaptopurine or azathioprine, or who are intolerant to or have medical contraindications for such therapies.” View full resource at news-medical.net
Most Recently Shared on January 21, 2012 at 9:30 am By:
Arthritis News: EMA CHMP issues positive opinion to MSD's REMICADE for treatment of pediatric UC: MSD today anno... http://t.co/qMuhwKHJ
Rheumatoid Arthritis Drugs May Increase Skin Cancer Risk
emaxhealth.com — “Use of rheumatoid arthritis drugs known as tumor necrosis factor (TNF) inhibitors (e.g., Enbrel, Remicade, others), may increase the risk of skin canc...” View full resource at emaxhealth.com
Most Recently Shared on September 9, 2011 at 5:42 pm By:
Rheumatoid Arthritis Drugs May Increase Skin Cancer Risk http://t.co/xkypDcQ
New report on the immunomodulators market outlook to 2016
news-medical.net — “TNF inhibitors indicated for the treatment of rheumatoid arthritis, psoriasis and inflammatory bowel disease formed the largest share of the market, according to a new report available on companiesandmarkets.com. The top three products: Remicade, Humira and Enbrel accounted for 40.1% of the market in 2010.” View full resource at news-medical.net
Most Recently Shared on August 23, 2011 at 10:39 am By:
Arthritis News: New report on the immunomodulators market outlook to 2016: TNF inhibitors indicated for the trea... http://t.co/1Xp7voQ
TNF Inhibitors Double Infection Risk - General Medicine
general-medicine.jwatch.org — “Tumor necrosis factor- (TNF) inhibitors raise risk for infection in patients with rheumatoid arthritis. To quantitate this risk, Japanese investigators compared outcomes in 646 patients who were treated with TNF inhibitors (etanercept [Enbrel] or infliximab . . .” View full resource at general-medicine.jwatch.org
Most Recently Shared on July 29, 2011 at 3:49 pm By:
For patients with early rheumatoid arthritis these medications favorably change the course of the disease. They... http://fb.me/DXLPICd3
Discontinuing Infliximab Can Benefit Early Rheumatoid Arthritis Patients : Internal Medicine News
internalmedicinenews.com — “Internal Medicine News Digital Network is the online destination and multimedia properties of Internal Medicine News, the independent news publication. Our breaking news covers all areas of internal medicine including adolescent medicine; cardiovascular disease; dermatology; diabetes, endocrinology and metabolism; gastroenterology; geriatric medicine; infectious diseases; mental health; oncology and hematology; nephrology and urology; neurology; pulmonary disease and sleep medicine; practice tre” View full resource at internalmedicinenews.com
Most Recently Shared on July 14, 2011 at 8:47 pm By:
80% of patients w early rheumatoid arthritis can discontinue infliximab for at least 1 year with no ill effects. http://bit.ly/ooWWR1
Rheumatology Article | Arthritis, Rheumatoid
mdlinx.com — “Which subgroup of rheumatoid arthritis patients benefits from switching to tocilizumab versus etanercept after previous infliximab failure? A retrospective study” View full resource at mdlinx.com
Most Recently Shared on July 8, 2011 at 8:30 am By:
Which subgroup of rheumatoid arthritis patients benefits from switching to tocilizumab versus etan... http://bit.ly/qxfXnA #Rheumatology
Family Medicine Article | Arthritis, Rheumatoid
mdlinx.com — “Which subgroup of rheumatoid arthritis patients benefits from switching to tocilizumab versus etanercept after previous infliximab failure? A retrospective study” View full resource at mdlinx.com
Most Recently Shared on July 7, 2011 at 6:04 pm By:
Which subgroup of rheumatoid arthritis patients benefits from switching to tocilizumab versus etane... http://bit.ly/prhAw8 #FamPractice
Rheumatology Article | Arthritis, Rheumatoid
mdlinx.com — “Discontinuation of infliximab and potential predictors of persistent low disease activity in patients with early rheumatoid arthritis and disease activity score-steered therapy: subanalysis of the BeSt study” View full resource at mdlinx.com
Most Recently Shared on May 6, 2011 at 5:55 pm By:
Discontinuation of infliximab and potential predictors of persistent low disease activity in patie... http://bit.ly/l8zytk #Rheumatology
Rheumatology Article | Arthritis, Rheumatoid
mdlinx.com — “Primary lack of efficacy of infliximab therapy for rheumatoid arthritis: pharmacokinetic characterization and assessment of switching to tocilizumab” View full resource at mdlinx.com
Most Recently Shared on May 5, 2011 at 5:43 pm By:
Primary lack of efficacy of infliximab therapy for rheumatoid arthritis: pharmacokinetic character... http://bit.ly/mnOAfI #Rheumatology
Rheumatology Article | Arthritis, Rheumatoid
mdlinx.com — “Baseline tumour necrosis factor alpha levels predict the necessity for dose escalation of infliximab therapy in patients with rheumatoid arthritis” View full resource at mdlinx.com
Most Recently Shared on April 22, 2011 at 9:17 pm By:
Baseline tumour necrosis factor alpha levels predict the necessity for dose escalation of inflixim... http://bit.ly/eK3tyb #Rheumatology
Medical News: BSR: Infliximab May Help in Resistant Arthritis - in Meeting Coverage, BSR from MedPage Today
medpagetoday.com — “BRIGHTON, England -- Infliximab (Remicade) remains an option for patients with longstanding rheumatoid arthritis who have not responded adequately to another tumor necrosis factor (TNF) inhibitor, res” View full resource at medpagetoday.com
Most Recently Shared on April 15, 2011 at 1:11 pm By:
BSR: Infliximab May Help in Resistant Arthritis (CME/CE) http://bit.ly/fF0X61
Remicade | Drug safety information | Monitoring several patients | MediGuard
mediguard.org — “Remicade | Drug safety information | Monitoring several patients | MediGuard” View full resource at mediguard.org
Most Recently Shared on March 12, 2011 at 10:17 pm By:
43% of #remicade users getting side-effects ... http://tinyurl.com/4hvtd3f
Related Medications - Medbroadcast
medbroadcast.com — “Top 5 adalimumab (Humira®) etanercept (Enbrel®) ibuprofen (Advil®, Motrin®, generics) infliximab (Remicade®) methylprednisolone acetate (Depo-Medrol®, generics) Others methotrexate (Methotrexate®, generics) naproxen (Naprosyn®, generics) prednisone (generics) sodium aurothiomalate ...” View full resource at medbroadcast.com
Most Recently Shared on December 6, 2010 at 3:37 pm By:
Get the facts on 16 common drugs used to treat psoriatic arthritis, including information about potential side... http://fb.me/NQ81IPlX
Rheumatology Article | Body Mass Index Arthritis, Rheumatoid
mdlinx.com — “Body mass index and clinical response to infliximab in rheumatoid arthritis” View full resource at mdlinx.com
Most Recently Shared on November 10, 2010 at 9:04 am By:
Body mass index and clinical response to infliximab in rheumatoid arthritis: Arthritis & Rheumatism http://bit.ly/cSDdHw #Rheumatology
Advertisement

